N-acyl amides {90000676}
| Parent: | [ ] |
|---|---|
| Definition: | N-acyl amides |
| Queue: | [ ] |
| Initialisation date: | [ ] |
|---|---|
| Specification: | |
| [ ] | |
| Source: | |
| [ ] | |
| Structural Type: | [ ] |
|---|---|
| Functional Type: | [ ] |
| Function: | [ ] |
Notes:
[ ]
Shared Reference Notes
- [1.1]
- The microbiome creates N-acyl amides (NAAs) that closely mimic the function of endogenously produced signaling molecules, particularly endocannabinoids. - The microbiome is capable of producing 6 families of N-acyl amides: N-acyl glycine, N-acyloxyacyl lysine, N-acyloxyacyl glutamine, N-acyl lysine/ornithine, N-acyl alanine, and N-acyl serinol. - These NAA mimics can serve as agonists or antagonists of G-protein-coupled receptors (GPCR). - Sample type can impact the NAAs detected in a study. - the majority of detected N-acyl homoserine molecules are present in serum, cecal content, and liver samples, some N-acyl homoserines are detected exclusively in one sample type, such as 3OH-C10-HSL only being detected in serum and C12-HSL only being detected in liver and cecal content. - it may be beneficial to collect at least one biofluid and one tissue sample based on the NAA of interest.
References Notes
[ ]